Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zenas BioPharma (ZBIO) Non Operating Income (2023 - 2025)

Zenas BioPharma (ZBIO) has 3 years of Non Operating Income data on record, last reported at $1.1 million in Q3 2025.

  • For Q3 2025, Non Operating Income fell 54.54% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $10.2 million, up 116.41%, while the annual FY2024 figure was $7.3 million, 2162.04% up from the prior year.
  • Non Operating Income reached $1.1 million in Q3 2025 per ZBIO's latest filing, down from $3.0 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $3.6 million in Q1 2025 and bottomed at -$16000.0 in Q3 2023.
  • Average Non Operating Income over 3 years is $1.9 million, with a median of $2.1 million recorded in 2024.
  • Peak YoY movement for Non Operating Income: skyrocketed 14962.5% in 2024, then plummeted 54.54% in 2025.
  • A 3-year view of Non Operating Income shows it stood at -$16000.0 in 2023, then surged by 16362.5% to $2.6 million in 2024, then crashed by 58.46% to $1.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $1.1 million in Q3 2025, $3.0 million in Q2 2025, and $3.6 million in Q1 2025.